Novo Nordisk's CagriSema trial raised concerns as patients reported weight loss but significant side effects. Investors ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

The new drug, amycretin, similar to the company's blockbuster weight-loss and diabetes drugs Wegovy and Ozempic ... weeks with incremental increases in dosage. The highest dose, 20 mg, provided ...

However, the extent of these benefits varies depending on the specific medication, dosage ... whereas Wegovy is specifically approved for weight loss. Who is it for? Wegovy is approved for ...